| Literature DB >> 23145997 |
Salaheddin M Mahmud1, Laura H Thompson, Deborah L Nowicki, Pierre J Plourde.
Abstract
BACKGROUND: Outbreaks of influenza-like illness (ILI) are common in long-term care facilities (LTCFs) and result in significant morbidity and mortality among residents.Entities:
Keywords: Epidemiology; influenza-like illness outbreaks; long-term care facilities
Mesh:
Year: 2012 PMID: 23145997 PMCID: PMC4634272 DOI: 10.1111/irv.12052
Source DB: PubMed Journal: Influenza Other Respir Viruses ISSN: 1750-2640 Impact factor: 4.380
Figure 1Number of reported influenza‐like illness (ILI) outbreaks by etiology and calendar year and quarter.
Characteristics of reported influenza‐like illness outbreaks by etiology
| Influenza A | Influenza B | Influenza | Other viruses | Unknown | All outbreaks | |
|---|---|---|---|---|---|---|
| Total no. of Outbreaks (% of all outbreaks) | 72 (46·8) | 8 (5·2) | 80 (52·0) | 12 (7·8) | 62 (40·3) | 154 |
| Residents | ||||||
| Median no. of residents per LTCF (Q1–Q3) | 150·0 (100·0–213·0) | 143·0 (109·0–155·0) | 150·0 (100·0–213·0) | 174·0 (105·0–216·0) | 155·0 (116·0–230·0) | 151·0 (110·5–216·5) |
| Median vaccination rate/100 residents (Q1–Q3) | 92·0 (88·0–95·1) | 91·0 (91·0–96·0) | 92·0 (88·2–95·1) | 90·5 (90·0–93·0) | 93·0 (89·0–95·8) | 92·0 (89·0–95·0) |
| Median attack rate/100 residents (Q1–Q3) | 7·4 (3·6–13·4) | 6·4 (1·7–9·7) | 7·2 (3·4–11·9) | 4·4 (2·8–7·7) | 4·4 (1·4–10·5) | 6·8 (2·6–11·1) |
| Mean death rate/1000 residents (SD) | 4·1 (7·0) | 6·7 (10·7) | 4·4 (7·4) | 2·4 (3·9) | 1·1 (3·1) | 2·9 (6·0) |
| Staff | ||||||
| Median no. of staff per LTCF (Q1–Q3) | 199·0 (128·8–305·0) | 200·0 (135·0–218·8) | 200·0 (130·0–300·0) | 227·5 (142·5–875·0) | 227·0 (150·0–489·0) | 200·0 (131·0–350·0) |
| Median vaccination rate/100 staff (Q1–Q3) | 38·0 (26·0–58·0) | 49·5 (41·0–52·0) | 40·0 (27·0–58·0) | 32·5 (27·9–37·8) | 37·9 (28·0–52·8) | 38·0 (28·0–55·0) |
| Median attack rate/100 staff (Q1–Q3) | 3·5 (0·6–7·4) | 3·1 (1·1–8·4) | 3·3 (0·7–7·3) | 0·8 (0·0–2·7) | 1·0 (0·0–5·2) | 1·7 (0·0–6·0) |
| Outbreak | ||||||
| No. of outbreaks for which chemoprophylaxis used (%) | 41 (56·9) | 5 (62·5) | 46 (57·5) | 0 (0·0) | 0 (0·0) | 46 (29·9) |
| Median duration of outbreak, days (Q1–Q3) | 16·0 (14·0–22·8) | 19·5 (14·0–45·3) | 16·0 (14·0–22·8) | 20·0 (15·8–29·5) | 21·0 (13·0–30·8) | 18·0 (14·0–26·3) |
| Median time to notification, days (Q1–Q3) | 2·0 (0·8–6·0) | 3·0 (1·8–6·0) | 2·0 (1·0–5·8) | 3·0 (0·0–9·8) | 3·0 (1·0–8·0) | 3·0 (1·0–7·0) |
| Median post‐notification duration, days (Q1–Q3) | 12·0 (11·0–17·5) | 15·0 (10·0–38·0) | 12·5 (11·0–17·8) | 17·5 (12·5–21·0) | 15·5 (11·3–22·5) | 14·0 (11·0–20·0) |
LTCF, long‐term care facility; Q1–Q3, first‐third quartile; SD, standard deviation.
Outcomes of reported influenza‐like illness outbreaks by etiology and reporting time, staff vaccination uptake, and use of chemoprophylaxis
| Influenza A | Influenza B | Influenza | Other viruses | Unknown | All outbreaks | |
|---|---|---|---|---|---|---|
| Duration of outbreak, median (Q1–Q3) | ||||||
| Outbreak reported in ≤3 days | 14·0 (12·0–19·3) | 15·0 (13·0–17·0) | 14·0 (12·0–17·8) | 18·0 (12·0–20·0) | 15·0 (11·0–21·0) | 14·0 (12·0–20·0) |
| Outbreak reported in >3 days | 22·0 (18·0–29·0) | 37·5 (22·0–53·0) | 22·0 (18·0–29·5) | 28·0 (21·0–34·5) | 31·5 (22·3–40·3) | 26·0 (21·0–35·0) |
| Staff vaccine uptake ≤38% | 16·0 (14·0–24·3) | 22·0 (13·0–53·0) | 16·0 (14·0–25·0) | 16·0 (16·0–16·0) | 17·0 (12·0–27·0) | 16·0 (13·5–24·0) |
| Staff vaccine uptake >38% | 16·0 (12·0–23·0) | 17·0 (17·0–17·0) | 16·5 (12·3–22·8) | 23·5 (18·3–32·5) | 27·5 (16·0–38·0) | 20·0 (14·0–28·8) |
| No chemoprophylaxis | 16·0 (14·0–24·5) | 22·0 (22·0–22·0) | 16·0 (14·0–24·0) | 20·0 (15·8–29·5) | 21·0 (13·0–30·8) | 20·0 (14·0–28·0) |
| Oseltamivir used | 16·0 (13·0–24·3) | 17·0 (13·0–53·0) | 16·0 (13·0–25·0) | – | – | 16·0 (13·0–25·0) |
| Amantadine used | 17·0 (14·0–21·8) | – | 17·0 (14·0–21·8) | – | – | 17·0 (14·0–21·8) |
| Residents’ attack rate (%), median (Q1–Q3) | ||||||
| Outbreak reported in ≤3 days | 7·0 (2·8–10·9) | 7·0 (4·4–9·2) | 7·0 (3·0–10·3) | 2·9 (0·9–3·4) | 3·4 (1·4–7·9) | 4·8 (2·1–9·0) |
| Outbreak reported in >3 days | 10·4 (5·4–18·4) | 1·3 (0·6–18·2) | 10·0 (4·5–18·2) | 7·5 (4·5–13·4) | 7·8 (1·6–11·5) | 8·1 (4·4–14·6) |
| Staff vaccine uptake ≤38% | 7·0 (4·3–13·2) | 5·0 (1·1–12·3) | 7·0 (3·0–11·7) | 4·2 (4·2–4·2) | 4·9 (2·3–10·5) | 6·6 (3·0–11·0) |
| Staff vaccine uptake >38% | 8·9 (3·4–13·4) | 8·0 (8·0–8·0) | 8·8 (3·4–12·9) | 4·6 (1·8–7·5) | 6·9 (1·9–10·8) | 7·1 (2·7–11·2) |
| No chemoprophylaxis | 10·0 (4·3–15·2) | 7·0 (0·6–18·2) | 9·5 (4·3–15·9) | 4·4 (2·8–7·7) | 4·4 (1·4–10·5) | 6·4 (2·5–11·2) |
| Oseltamivir used | 7·0 (2·0–11·7) | 5·9 (2·1–9·2) | 6·9 (2·0–11·3) | – | – | 6·9 (2·0–11·3) |
| Amantadine used | 6·7 (3·8–9·8) | – | 6·7 (3·8–9·8) | – | – | 6·7 (3·8–9·8) |
| Residents’ death rate (/1000), mean (SD) | ||||||
| Outbreak reported in ≤3 days | 3·3 (6·4) | 5·9 (13·2) | 3·6 (7·2) | 0·8 (1·9) | 0·3 (1·6) | 2·1 (5·6) |
| Outbreak reported in >3 days | 5·4 (7·8) | 8·1 (7·0) | 5·6 (7·7) | 4·0 (4·8) | 2·3 (4·2) | 4·1 (6·3) |
| Staff vaccine uptake ≤38% | 5·0 (8·1) | 8·9 (11·7) | 5·6 (8·6) | 0·0 (.) | 1·5 (3·9) | 4·0 (7·4) |
| Staff vaccine uptake >38% | 3·7 (6·2) | 0·0 (.) | 3·6 (6·1) | 3·2 (4·2) | 1·0 (3·0) | 2·7 (5·2) |
| No chemoprophylaxis | 3·2 (6·2) | 3·8 (6·6) | 3·3 (6·2) | 2·4 (3·9) | 1·1 (3·1) | 1·9 (4·4) |
| Oseltamivir used | 3·3 (6·2) | 8·5 (13·0) | 4·2 (7·7) | – | – | 4·2 (7·7) |
| Amantadine used | 6·9 (9·0) | – | 6·9 (9·0) | – | – | 6·9 (9·0) |
| Staff attack rate (%), median (Q1–Q3) | ||||||
| Outbreak reported in ≤3 days | 2·8 (0·3–7·7) | 3·1 (2·2–4·0) | 3·1 (0·5–7·3) | 0·0 (0·0–1·4) | 0·5 (0·0–3·0) | 1·3 (0·0–4·9) |
| Outbreak reported in >3 days | 3·7 (0·8–7·2) | 6·4 (0·0–12·8) | 3·7 (0·7–7·4) | 1·3 (0·0–5·9) | 2·3 (0·9–6·0) | 3·1 (0·8–6·6) |
| Staff vaccine uptake ≤38% | 4·0 (0·5–7·0) | 3·5 (0·8–10·6) | 4·0 (0·5–7·0) | 0·0 (0·0–0·0) | 2·1 (0·0–8·8) | 3·2 (0·0–7·1) |
| Staff vaccine uptake >38% | 2·7 (0·6–9·4) | – | 2·7 (0·6–9·4) | 0·8 (0·0–1·8) | 0·9 (0·0–5·3) | 1·3 (0·3–5·9) |
| No chemoprophylaxis | 4·3 (0·8–9·0) | 7·9 (3·1–12·8) | 4·3 (0·8–9·9) | 0·8 (0·0–2·7) | 1·0 (0·0–5·2) | 1·6 (0·0–6·1) |
| Oseltamivir used | 1·3 (0·3–5·7) | 2·2 (0·0–4·0) | 1·7 (0·3–4·8) | – | – | 1·7 (0·3–4·8) |
| Amantadine used | 3·3 (0·8–8·7) | – | 3·3 (0·8–8·7) | – | – | 3·3 (0·8–8·7) |
Q1–Q3, first–third quartile; SD, standard deviation.
Relative risk estimates (95% confidence intervals) from generalized estimating equation (GEE) models of the association between listed variables and outbreak duration and residents’ attack rates
| Outbreak duration, geometric mean | Residents’ attack rate, geometric mean | |
|---|---|---|
| All outbreaks | ||
| Outbreak reported in >3 days | 1·6 (1·3–2·0) | 1·8 (1·3–2·5) |
| Staff vaccine uptake ≤38% | 1·1 (0·9–1·4) | 1·2 (0·9–1·6) |
| No. of residents | 1·0 (1·0–1·0) | 1·0 (1·0–1·0) |
| No. of staff | 1·0 (1·0–1·0) | 1·0 (1·0–1·0) |
| Etiology | ||
| Influenza A | Ref | Ref |
| Influenza B | 1·2 (0·8–1·8) | 0·6 (0·2–1·3) |
| Other viruses | 1·3 (1·0–1·8) | 0·6 (0·4–0·8) |
| Unknown | 1·0 (0·8–1·3) | 0·7 (0·5–0·9) |
| Influenza outbreaks only | ||
| Outbreak reported in >3 days | 1·5 (1·2–1·8) | 1·5 (1·0–2·4) |
| Staff vaccine uptake ≤38% | 1·0 (0·8–1·3) | 1·5 (1·0–2·3) |
| No. of residents | 1·0 (1·0–1·0) | 1·0 (1·0–1·0) |
| No. of staff | 1·0 (1·0–1·0) | 1·0 (1·0–1·0) |
| Chemoprophylaxis used | 1·0 (0·7–1·3) | 0·9 (0·6–1·5) |